Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?

Objectives: Pulmonary hypertension (PH) is commonly observed in patients with diffuse parenchymal lung disease (DPLD). The purpose of this study was to explore the influence of the 6-minute walk test (6MWT) as a simple, non-invasive tool to assess right ventricular (RV) function in patients with DPL...

Full description

Bibliographic Details
Main Authors: Kamonpun Ussavarungsi, Augustine S. Lee, Charles D. Burger
Format: Article
Language:English
Published: Oman Medical Specialty Board 2016-09-01
Series:Oman Medical Journal
Subjects:
Online Access:http://omjournal.org/articleDetails.aspx?coType=1&aId=1808
id doaj-a1fd2fd5c177491c935db4da727cfe04
record_format Article
spelling doaj-a1fd2fd5c177491c935db4da727cfe042020-11-25T00:08:19ZengOman Medical Specialty BoardOman Medical Journal1999-768X2070-52042016-09-0131534535110.5001/omj.2016.69Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?Kamonpun Ussavarungsi0Augustine S. Lee1Charles D. Burger2Pulmonary Medicine, Mayo Clinic, Rochester, Minnesota, USAPulmonary Medicine, Mayo Clinic, Jacksonville, Florida, USAPulmonary Medicine, Mayo Clinic, Jacksonville, Florida, USAObjectives: Pulmonary hypertension (PH) is commonly observed in patients with diffuse parenchymal lung disease (DPLD). The purpose of this study was to explore the influence of the 6-minute walk test (6MWT) as a simple, non-invasive tool to assess right ventricular (RV) function in patients with DPLD and to identify the need for an echocardiogram (ECHO) to screen for PH. Methods: We retrospectively reviewed 48 patients with PH secondary to DPLD, who were evaluated in the PH clinic at the Mayo Clinic in Jacksonville, Florida, from January 1999 to December 2014. Results: Fifty-two percent of patients had RV dysfunction. They had a significantly greater right heart pressure by ECHO and mean pulmonary arterial pressure (MPAP) from right heart catheterization (RHC) than those with normal RV function. A reduced 6-minute walk distance (6MWD) did not predict RV dysfunction (OR 0.995; 95% CI 0.980–1.001, p = 0.138). In addition, worsening restrictive physiology, heart rate at one-minute recovery and desaturation were not different between patients with and without RV dysfunction. However, there were inverse correlations between 6MWD and MPAP from RHC (r = -0.41, p = 0.010), 6MWD and RV systolic pressure (r = -0.51, p < 0.001), and 6MWD and MPAP measured by ECHO (r = -0.46, p =0.013). We also found no significant correlation between 6MWD and pulmonary function test parameters. Conclusions: Our single-center cohort of patients with PH secondary to DPLD, PH was found to have an impact on 6MWD. In contrast to our expectations, 6MWD was not useful to predict RV dysfunction. Interestingly, a severe reduction in the 6MWD was related to PH and not to pulmonary function; therefore, it may be used to justify an ECHO to identify patients with a worse prognosis.http://omjournal.org/articleDetails.aspx?coType=1&aId=1808Diffuse Parenchymal Lung DiseasesInterstitial Lung DiseasesPulmonary Hypertension6-minute walk distanceEchocardiogram
collection DOAJ
language English
format Article
sources DOAJ
author Kamonpun Ussavarungsi
Augustine S. Lee
Charles D. Burger
spellingShingle Kamonpun Ussavarungsi
Augustine S. Lee
Charles D. Burger
Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?
Oman Medical Journal
Diffuse Parenchymal Lung Diseases
Interstitial Lung Diseases
Pulmonary Hypertension
6-minute walk distance
Echocardiogram
author_facet Kamonpun Ussavarungsi
Augustine S. Lee
Charles D. Burger
author_sort Kamonpun Ussavarungsi
title Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?
title_short Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?
title_full Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?
title_fullStr Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?
title_full_unstemmed Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?
title_sort can a six-minute walk distance predict right ventricular dysfunction in patients with diffuse parenchymal lung disease and pulmonary hypertension?
publisher Oman Medical Specialty Board
series Oman Medical Journal
issn 1999-768X
2070-5204
publishDate 2016-09-01
description Objectives: Pulmonary hypertension (PH) is commonly observed in patients with diffuse parenchymal lung disease (DPLD). The purpose of this study was to explore the influence of the 6-minute walk test (6MWT) as a simple, non-invasive tool to assess right ventricular (RV) function in patients with DPLD and to identify the need for an echocardiogram (ECHO) to screen for PH. Methods: We retrospectively reviewed 48 patients with PH secondary to DPLD, who were evaluated in the PH clinic at the Mayo Clinic in Jacksonville, Florida, from January 1999 to December 2014. Results: Fifty-two percent of patients had RV dysfunction. They had a significantly greater right heart pressure by ECHO and mean pulmonary arterial pressure (MPAP) from right heart catheterization (RHC) than those with normal RV function. A reduced 6-minute walk distance (6MWD) did not predict RV dysfunction (OR 0.995; 95% CI 0.980–1.001, p = 0.138). In addition, worsening restrictive physiology, heart rate at one-minute recovery and desaturation were not different between patients with and without RV dysfunction. However, there were inverse correlations between 6MWD and MPAP from RHC (r = -0.41, p = 0.010), 6MWD and RV systolic pressure (r = -0.51, p < 0.001), and 6MWD and MPAP measured by ECHO (r = -0.46, p =0.013). We also found no significant correlation between 6MWD and pulmonary function test parameters. Conclusions: Our single-center cohort of patients with PH secondary to DPLD, PH was found to have an impact on 6MWD. In contrast to our expectations, 6MWD was not useful to predict RV dysfunction. Interestingly, a severe reduction in the 6MWD was related to PH and not to pulmonary function; therefore, it may be used to justify an ECHO to identify patients with a worse prognosis.
topic Diffuse Parenchymal Lung Diseases
Interstitial Lung Diseases
Pulmonary Hypertension
6-minute walk distance
Echocardiogram
url http://omjournal.org/articleDetails.aspx?coType=1&aId=1808
work_keys_str_mv AT kamonpunussavarungsi canasixminutewalkdistancepredictrightventriculardysfunctioninpatientswithdiffuseparenchymallungdiseaseandpulmonaryhypertension
AT augustineslee canasixminutewalkdistancepredictrightventriculardysfunctioninpatientswithdiffuseparenchymallungdiseaseandpulmonaryhypertension
AT charlesdburger canasixminutewalkdistancepredictrightventriculardysfunctioninpatientswithdiffuseparenchymallungdiseaseandpulmonaryhypertension
_version_ 1725415731332382720